These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 32940324

  • 1. Two- and three-photon excitable quaternized imidazo[1,2-a]pyridines as mitochondrial imaging and potent cancer therapy agents.
    Hase E, Takanari H, Hoshi K, Okamoto M, Tabata A, Nagamune H, Minamikawa T, Yasui T, Yoshida Y, Minagawa K, Kawamura Y, Imada Y, Yagishita F.
    Org Biomol Chem; 2020 Oct 07; 18(38):7571-7576. PubMed ID: 32940324
    [Abstract] [Full Text] [Related]

  • 2. Bright, fluorescent dyes based on imidazo[1,2-a]pyridines that are capable of two-photon absorption.
    Firmansyah D, Ciuciu AI, Hugues V, Blanchard-Desce M, Flamigni L, Gryko DT.
    Chem Asian J; 2013 Jun 07; 8(6):1279-94. PubMed ID: 23564658
    [Abstract] [Full Text] [Related]

  • 3. Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.
    Garamvölgyi R, Dobos J, Sipos A, Boros S, Illyés E, Baska F, Kékesi L, Szabadkai I, Szántai-Kis C, Kéri G, Őrfi L.
    Eur J Med Chem; 2016 Jan 27; 108():623-643. PubMed ID: 26724730
    [Abstract] [Full Text] [Related]

  • 4. Discovery and SAR study of 2-(1-propylpiperidin-4-yl)-3H-imidazo[4,5-c]pyridine-7-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase-1 (PARP-1) for the treatment of cancer.
    Zhu Q, Wang X, Hu Y, He X, Gong G, Xu Y.
    Bioorg Med Chem; 2015 Oct 15; 23(20):6551-9. PubMed ID: 26422786
    [Abstract] [Full Text] [Related]

  • 5. Exploration of imidazole and imidazopyridine dimers as anticancer agents: Design, synthesis, and structure-activity relationship study.
    Meenakshisundaram S, Manickam M, Pillaiyar T.
    Arch Pharm (Weinheim); 2019 Dec 15; 352(12):e1900011. PubMed ID: 31596021
    [Abstract] [Full Text] [Related]

  • 6. Design, synthesis and structure--activity relationship (SAR) studies of imidazo[4,5-b]pyridine derived purine isosteres and their potential as cytotoxic agents.
    Sajith AM, Abdul Khader KK, Joshi N, Reddy MN, Syed Ali Padusha M, Nagaswarupa HP, Nibin Joy M, Bodke YD, Karuvalam RP, Banerjee R, Muralidharan A, Rajendra P.
    Eur J Med Chem; 2015 Jan 07; 89():21-31. PubMed ID: 25462222
    [Abstract] [Full Text] [Related]

  • 7. 3-[4-(1H-indol-3-yl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridines, nortopsentin analogues with antiproliferative activity.
    Parrino B, Carbone A, Di Vita G, Ciancimino C, Attanzio A, Spanò V, Montalbano A, Barraja P, Tesoriere L, Livrea MA, Diana P, Cirrincione G.
    Mar Drugs; 2015 Apr 03; 13(4):1901-24. PubMed ID: 25854642
    [Abstract] [Full Text] [Related]

  • 8. Design and synthesis of novel imidazo[4,5-b]pyridine based compounds as potent anticancer agents with CDK9 inhibitory activity.
    Ghanem NM, Farouk F, George RF, Abbas SES, El-Badry OM.
    Bioorg Chem; 2018 Oct 03; 80():565-576. PubMed ID: 30025343
    [Abstract] [Full Text] [Related]

  • 9. Coordination geometry-induced optical imaging of l-cysteine in cancer cells using imidazopyridine-based copper(ii) complexes.
    Priyanga S, Khamrang T, Velusamy M, Karthi S, Ashokkumar B, Mayilmurugan R.
    Dalton Trans; 2019 Jan 28; 48(4):1489-1503. PubMed ID: 30632585
    [Abstract] [Full Text] [Related]

  • 10. Tricyclic series of heat shock protein 90 (Hsp90) inhibitors part I: discovery of tricyclic imidazo[4,5-c]pyridines as potent inhibitors of the Hsp90 molecular chaperone.
    Vallée F, Carrez C, Pilorge F, Dupuy A, Parent A, Bertin L, Thompson F, Ferrari P, Fassy F, Lamberton A, Thomas A, Arrebola R, Guerif S, Rohaut A, Certal V, Ruxer JM, Gouyon T, Delorme C, Jouanen A, Dumas J, Grépin C, Combeau C, Goulaouic H, Dereu N, Mikol V, Mailliet P, Minoux H.
    J Med Chem; 2011 Oct 27; 54(20):7206-19. PubMed ID: 21972823
    [Abstract] [Full Text] [Related]

  • 11. The discovery of novel imidazo[1,2-a]pyridine derivatives as covalent anticancer agents.
    Song Q, Zhang Q, Fan X, Kayaat F, Lv R, Li J, Wang Y.
    Org Biomol Chem; 2024 Jul 03; 22(26):5374-5384. PubMed ID: 38869445
    [Abstract] [Full Text] [Related]

  • 12. Synthesis, mitochondrial localization of fluorescent derivatives of cinnamamide as anticancer agents.
    Yang K, Li Y, Tang Q, Zheng L, He D.
    Eur J Med Chem; 2019 May 15; 170():45-54. PubMed ID: 30878831
    [Abstract] [Full Text] [Related]

  • 13. Discovery of a new series of imidazo[1,2-a]pyridine compounds as selective c-Met inhibitors.
    Liu TC, Peng X, Ma YC, Ji YC, Chen DQ, Zheng MY, Zhao DM, Cheng MS, Geng MY, Shen JK, Ai J, Xiong B.
    Acta Pharmacol Sin; 2016 May 15; 37(5):698-707. PubMed ID: 27041462
    [Abstract] [Full Text] [Related]

  • 14. Bright Near-Infrared Aggregation-Induced Emission Luminogens with Strong Two-Photon Absorption, Excellent Organelle Specificity, and Efficient Photodynamic Therapy Potential.
    Zheng Z, Zhang T, Liu H, Chen Y, Kwok RTK, Ma C, Zhang P, Sung HHY, Williams ID, Lam JWY, Wong KS, Tang BZ.
    ACS Nano; 2018 Aug 28; 12(8):8145-8159. PubMed ID: 30074773
    [Abstract] [Full Text] [Related]

  • 15. 5-(Dimethylamino)-N-(4-ethynylphenyl)-1-naphthalenesulfonamide as a novel bifunctional antitumor agent and two-photon induced bio-imaging probe.
    Chui CH, Wang Q, Chow WC, Yuen MC, Wong KL, Kwok WM, Cheng GY, Wong RS, Tong SW, Chan KW, Lau FY, Lai PB, Lam KH, Fabbri E, Tao XM, Gambari R, Wong WY.
    Chem Commun (Camb); 2010 May 28; 46(20):3538-40. PubMed ID: 20379581
    [Abstract] [Full Text] [Related]

  • 16. Imidazopyridine derivatives as potent and selective Polo-like kinase (PLK) inhibitors.
    Sato Y, Onozaki Y, Sugimoto T, Kurihara H, Kamijo K, Kadowaki C, Tsujino T, Watanabe A, Otsuki S, Mitsuya M, Iida M, Haze K, Machida T, Nakatsuru Y, Komatani H, Kotani H, Iwasawa Y.
    Bioorg Med Chem Lett; 2009 Aug 15; 19(16):4673-8. PubMed ID: 19589677
    [Abstract] [Full Text] [Related]

  • 17. Novel amino substituted tetracyclic imidazo[4,5-b]pyridine derivatives: Design, synthesis, antiproliferative activity and DNA/RNA binding study.
    Lončar B, Perin N, Mioč M, Boček I, Grgić L, Kralj M, Tomić S, Stojković MR, Hranjec M.
    Eur J Med Chem; 2021 May 05; 217():113342. PubMed ID: 33751978
    [Abstract] [Full Text] [Related]

  • 18. Mitochondrial targeted osmium polypyridyl probe shows concentration dependent uptake, localisation and mechanism of cell death.
    Gkika KS, Byrne A, Keyes TE.
    Dalton Trans; 2019 Dec 03; 48(47):17461-17471. PubMed ID: 31513202
    [Abstract] [Full Text] [Related]

  • 19. A FRET ratiometric fluorescent probe for detection of Hg2+ based on an imidazo[1,2-a]pyridine-rhodamine system.
    Li Y, Qi S, Xia C, Xu Y, Duan G, Ge Y.
    Anal Chim Acta; 2019 Oct 24; 1077():243-248. PubMed ID: 31307715
    [Abstract] [Full Text] [Related]

  • 20. Optimization of imidazo[4,5-b]pyridine-based kinase inhibitors: identification of a dual FLT3/Aurora kinase inhibitor as an orally bioavailable preclinical development candidate for the treatment of acute myeloid leukemia.
    Bavetsias V, Crumpler S, Sun C, Avery S, Atrash B, Faisal A, Moore AS, Kosmopoulou M, Brown N, Sheldrake PW, Bush K, Henley A, Box G, Valenti M, de Haven Brandon A, Raynaud FI, Workman P, Eccles SA, Bayliss R, Linardopoulos S, Blagg J.
    J Med Chem; 2012 Oct 25; 55(20):8721-34. PubMed ID: 23043539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.